Description
The abstract reports selective effects on dopamine, adrenaline, and noradrenaline but no impact on serotonin or histamine systems. This selectivity pattern is unexplained and understanding it could reveal novel therapeutic targets for neurotransmitter modulation.
Gap type: unexplained_observation Source paper: Atremorine in Parkinson’s disease: From dopaminergic neuroprotection to pharmacogenomics. (2021, Med Res Rev, PMID:34106485)